The aim of the study was to follow the rate of high blood pressure and dyslipidemia in industrial workers in relation to experience under intense noise and a hot environment. We studied 545 male industrial workers comprising 271 subjects working under intense noise (86 to 92 dba), 159 subjects exposed to heat [wet bulb globe temperature of 35.4 degrees C (28.4-41.7 degrees C)], and a control group of 115 subjects with experience of <9; 10-19, or >20 y, which paralleled the age groups of young (< 32 y); middle-aged (33-45 y), and aged workers (> 46 y). Arterial pressure, anthropometric variables, lipid status, smoking, and alcohol use were monitored. The rate of blood pressure > 140/90 mmHg was significantly higher in noise-exposed middle-aged workers and in both exposed groups of aged workers (p < .05). The rate of dyslipidemia was significantly higher in heat-exposed middle-aged workers and in both exposed groups of aged workers (p < .05). Summing up, our data suggest that long-term work under intensive noise or in a hot environment is associated with a greater chance of becoming hypertensive and dyslipidemic. Exposure to noise was related to elevated blood pressure, whereas heat exposure was related to deviations in serum lipids.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1515/reveh.2007.22.4.303 | DOI Listing |
J Med Internet Res
January 2025
Centre for Research in Media and Communication, Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia, Selangor, Malaysia.
Background: Cardiovascular disease (CVD) is a major global health issue, with approximately 70% of cases linked to modifiable risk factors. Digital health solutions offer potential for CVD prevention; yet, their effectiveness in covering the full range of prevention strategies is uncertain.
Objective: This study aimed to synthesize current literature on digital solutions for CVD prevention, identify the key components of effective digital interventions, and highlight critical research gaps to inform the development of sustainable strategies for CVD prevention.
Int J Clin Pharm
January 2025
Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
Background: Deprescribing inappropriate cardiovascular and antidiabetic medication has been shown to be feasible and safe. Healthcare providers often perceive the deprescribing of cardiovascular and antidiabetic medication as a challenge and therefore it is still not widely implemented in daily practice.
Aim: The aim was to assess whether training focused on conducting a deprescribing-oriented clinical medication review (CMR) results in a reduction of the inappropriate use of cardiovascular and antidiabetic medicines.
World J Pediatr
January 2025
Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China.
Background: We performed an umbrella review to synthesize evidence on the effects of physical activity (PA) interventions on indicators of physical and psychological health among children and adolescents, including body mass index (BMI), blood pressure (BP), depressive symptoms, and cognitive function.
Methods: PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from inception through 31 July 2023. We included meta-analyses of randomized controlled trials exploring the effects of PA interventions on BMI, BP, depressive symptoms, or cognitive function in healthy or general children and adolescents.
Curr Cardiol Rep
January 2025
John Ochsner Heart and Vascular Institute, Ochsner Clinical School University of Queensland School of Medicine, New Orleans, LA, USA.
Purpose Of Review: To provide a narrative overview of trends and disparities in the cardiometabolic profiles of U.S. adults by synthesizing findings from nationally representative studies conducted between 1999 and 2020.
View Article and Find Full Text PDFMinerva Cardiol Angiol
January 2025
Department of Neurology, Traditional Chinese Medical Hospital of Huzhou, Huzhou, Zhejiang, China -
Introduction: The current meta-analysis aimed to determine the efficacy of propolis supplementation on hypertension.
Evidence Acquisition: The systematic review and meta-analysis. were undertaken on five online databases to find clinical trials assessing the effects of propolis on systolic blood pressure (SBP) and diastolic blood pressure (DBP) markers up to October 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!